Last updated on March 2019

Ceramide NanoLiposome in Patients With Advanced Solid Tumors


Brief description of study

This study is a dose escalation study of Ceramide NanoLiposome in patients with advanced solid tumors.

Clinical Study Identifier: NCT02834611

Find a site near you

Start Over